Gender Differences and Cardiovascular Drugs | Ten Points to Remember The May 15, 2015 issue of the Journal of the American College of Cardiology contains a brilliant list of gender differences in drugs used to treat cardiovascular disease. Gender variations in Pharmokinetics and pharmacodynamics are discussed. The authors discuss differences in rates of metabolism, onset […]
Blood Pressure, Body Composition, body weight, Calcium Channel Blockers, Cardiology, Cardiovascular Agents, Contraceptives, Digoxin, Diuretics, Drug-Related Side Effects and Adverse Reactions, medication, Oral, Pharmacology, Primary Prevention
Estimates of benefits and harms of prophylactic use of aspirin in the general population In this fascinating study of available data in the Annals of Oncology journal, it was found that 10 years of regular low dose aspirin use was associated with a 7% reduction in the risk of cancer, MI, and stroke among women, […]
Cancer, Cardiovascular disease, heart disease, medication, prevention, strokeEstimates of benefits and harms of prophylactic useof aspirin in the general population Background: Accumulating evidence supports an effect of aspirin in reducing overall cancer incidence and mortality in the general population. We reviewed current data and assessed the benefits and harms of prophylactic use of aspirin in the general population. Methods: The effect of […]
Cancer, Cardiovascular disease, heart disease, medication, preventionAre Women Appropriately and Adequately Included in Clinical Trials of Moxifloxacin? Elisa Chilet-Rosell, PhD,1 Ma Teresa Ruiz-Cantero,1,2 and Ma Angeles Pardo, MSc11Public Health Research Group, University of Alicante, Alicante, Spain.2CIBER Epidemiología y Salud Pública (CIBERESP), Spain. [email protected] ABSTRACT Purpose: To determine the inclusion of women and the sex-stratification of results in moxifloxacin Clinical Trials (CTs), […]
Clinical trials, medication, Pharmacology, prescription drugs